These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2130921)

  • 21. Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-gamma-knockout mice.
    Afanasyeva M; Georgakopoulos D; Fairweather D; Caturegli P; Kass DA; Rose NR
    Circulation; 2004 Nov; 110(18):2910-7. PubMed ID: 15505106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relation of cardiac diastolic elasticity to its adaptation to loading].
    Kapel'ko VI; Novikova NA
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):970-6. PubMed ID: 3181539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection from adriamycin-induced cardiomyopathy in rats.
    Shug AL
    Z Kardiol; 1987; 76 Suppl 5():46-52. PubMed ID: 3433883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular and molecular mechanisms of systolic and diastolic dysfunction in an avian model of dilated cardiomyopathy.
    Wu Y; Tobias AH; Bell K; Barry W; Helmes M; Trombitas K; Tucker R; Campbell KB; Granzier HL
    J Mol Cell Cardiol; 2004 Jul; 37(1):111-9. PubMed ID: 15242741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Furazolidone-induced congestive cardiomyopathy in ducklings: myocardial ultrastructural alterations.
    Van Vleet JF; Ferrans VJ
    Am J Vet Res; 1983 Jun; 44(6):1014-23. PubMed ID: 6870005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer.
    Sakata S; Lebeche D; Sakata Y; Sakata N; Chemaly ER; Liang LF; Padmanabhan P; Konishi N; Takaki M; del Monte F; Hajjar RJ
    Mol Ther; 2006 May; 13(5):987-96. PubMed ID: 16503203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of physical overloads on the state of the cardiomyocytes in experimental autoimmune cardiomyopathy].
    Sharov VG; Bykovskaia KN; Saks VA
    Arkh Patol; 1979; 41(2):15-21. PubMed ID: 426643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial alterations induced by prolonged noradrenaline administration in various doses.
    Popovich MI; Kobets VA; Kostin SI; Kapelko VI
    Clin Cardiol; 1992 Sep; 15(9):660-5. PubMed ID: 1395201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Norepinephrine-induced heart failure and the protective effect of taurine].
    Popovich MI; Kobets VA; Kapel'ko VI
    Fiziol Zh (1978); 1990; 36(6):8-12. PubMed ID: 2083593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between cardiac energy metabolism and gain of left ventricular mass in Fabry disease.
    Palecek T; Bultas J; Hajek M; Karetova D; Kuchynka P; Kautzner J; Elleder M; Linhart A
    Int J Cardiol; 2010 Oct; 144(2):337-9. PubMed ID: 19344961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac pump function of the isolated rat heart at two modes of energy deprivation and effect of adrenergic stimulation.
    Kapelko VI; Lakomkin VL; Korchazhkina OV; Pisarenko OI
    Mol Cell Biochem; 1996; 163-164():131-6. PubMed ID: 8974048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and histologic correlates of ventricular end-diastolic pressure.
    Unverferth DV; Magorien RD; Kolibash AJ; Lewis RP; Lykens M; Altschuld R; Baba N; Leier CV
    Int J Cardiol; 1981; 1(2):133-42. PubMed ID: 7338417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of verapamil in diabetic cardiomyopathy.
    Afzal N; Ganguly PK; Dhalla KS; Pierce GN; Singal PK; Dhalla NS
    Diabetes; 1988 Jul; 37(7):936-42. PubMed ID: 3384188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease.
    Weber KT; Sun Y; Gerling IC; Guntaka RV
    Am J Hypertens; 2017 Nov; 30(11):1049-1052. PubMed ID: 28379281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation, long-term culture, and ultrastructural characterization of adult cardiomyopathic cardiac muscle cells.
    Nag AC; Cheng M
    In Vitro Cell Dev Biol; 1987 Apr; 23(4):261-6. PubMed ID: 3571099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interrelation of left ventricular function and myocardial ultrastructure as assessed by endomyocardial biopsy: comparative study of hypertrophic and congestive cardiomyopathies.
    Sekiguchi M; Haze K; Hiroe M; Konno S; Hirosawa K
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():327-34. PubMed ID: 1031987
    [No Abstract]   [Full Text] [Related]  

  • 37. Myofibrillar abnormalities following cardiac muscle cell injury.
    Ferrans VJ; Buja LM; Maron BJ
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():367-82. PubMed ID: 1105713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal myocardial calcium handling in the early stage of adriamycin cardiomyopathy.
    Kapelko VI; Williams CP; Gutstein DE; Morgan JP
    Arch Physiol Biochem; 1996; 104(2):185-91. PubMed ID: 8818203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial connective tissue alterations.
    Caulfield JB; Wolkowicz PE
    Toxicol Pathol; 1990; 18(4 Pt 1):488-96. PubMed ID: 2091228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicular myocardial change: an ultrastructural study of double membrane-bound vesicles in the human heart.
    Vega KE; Hawk WA; Shirey EK; Osborne DG
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():731-69. PubMed ID: 1209014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.